Literature DB >> 20068048

Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines.

D G Grosset1, G J A Macphee, M Nairn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20068048     DOI： 10.1136/bmj.b5614

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Safinamide: first global approval.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

2.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

3.  Part 2: Introduction to the Pharmacotherapy of Parkinson's Disease, With a Focus on the Use of Dopaminergic Agents.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-09

4.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

Review 5.  Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review.

Authors:  Eugene Y H Yeung; Andrea E Cavanna
Journal:  Mov Disord Clin Pract       Date:  2014-09-01

Review 6.  [Relevance of COMT inhibitors in the treatment of motor fluctuations].

Authors:  Wolfgang H Jost; Carsten Buhmann; Joseph Classen; Karla Eggert; Zacharias Kohl; Tiago Outeiro; Lars Tönges; Dirk Woitalla; Heinz Reichmann
Journal:  Nervenarzt       Date:  2022-01-19       Impact factor: 1.297

Review 7.  Lower limb progressive resistance training improves leg strength but not gait speed or balance in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Alex Tillman; Makii Muthalib; Ashlee M Hendy; Liam G Johnson; Timo Rantalainen; Dawson J Kidgell; Peter G Enticott; Wei-Peng Teo
Journal:  Front Aging Neurosci       Date:  2015-03-24       Impact factor: 5.750

Review 8.  Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.

Authors:  Zahra Goodarzi; Bria Mele; Selynne Guo; Heather Hanson; Nathalie Jette; Scott Patten; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  BMC Neurol       Date:  2016-11-25       Impact factor: 2.474

Review 9.  Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.

Authors:  Jie Dong; Yanhua Cui; Song Li; Weidong Le
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease.

Authors:  Luca Loprete; Chiara Leuratti; Carlo Cattaneo; Mita M Thapar; Colm Farrell; Marco Sardina
Journal:  Pharmacol Res Perspect       Date:  2016-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.